On 2 November, Anthropic amended its filing to go public. Ticker ANT, Nasdaq Global Select Market. That one made the news.
Eight other companies filed in the same week. Their filings are just as public and run to hundreds of pages each, with the numbers that matter (revenue, losses, how much cash is left) somewhere in the middle. So we asked an agent to read them.
It took one call to Financial Datasets, which classifies every IPO filing and pulls the financial statements out of it. The ten newest filings, 16 cents, back in seconds. Nine came from that week, plus one amendment from July.
Two biotechs, two runways
On the evening of 30 October, two biotech companies filed their final prospectuses, the document that sets the share price. Bambusa Therapeutics priced at $16. Aspen Neuroscience priced at $15.
Both are still before their first revenue, so the interesting number is cash. Bambusa lost $48.7 million over the last twelve months and had $46.5 million in the bank at the end of June: about eleven months at that pace. Aspen lost $66.8 million and had $21.3 million: under four months.
The profitable one with $68,526
Timwood Holdings is the only one of the six with numbers that made money: $7.8 million in revenue and $0.9 million in profit over its last financial year. It wants to sell shares at $4 to $6.
At the end of June, it had $68,526 in cash. A year earlier it had $985,429.
And the rest
KAT Construction Services, a contractor heading for NYSE American, made a profit in 2025 and a small loss over the last twelve months, on $12.6 million in revenue. NuvOx Therapeutics brings in about $1 million a year and has $32.0 million in liabilities against $2.1 million in assets. Starton Holdings is still before revenue and lost $15.2 million.
Here is the whole list, with numbers over the last twelve months where the filing had them extracted:
| Company | Ticker | Status | Revenue | Net result | Cash |
|---|---|---|---|---|---|
| Anthropic | ANT, Nasdaq | Amended filing, 2 Nov | in the filing | in the filing | in the filing |
| Bambusa Therapeutics | BBTX, Nasdaq | Priced at $16, 30 Oct | none yet | loss of $48.7M | $46.5M |
| Aspen Neuroscience | ASPE, Nasdaq | Priced at $15, 30 Oct | none yet | loss of $66.8M | $21.3M |
| Timwood Holdings | TIWD, Nasdaq | $4 to $6 range, 30 Oct | $7.8M | profit of $0.9M | $0.07M |
| Windward Bio | WWB, Nasdaq | Amended filing, 30 Oct | in the filing | in the filing | in the filing |
| Tracx Logis | TRCX, Nasdaq | $18 to $22 range, 29 Oct | in the filing | in the filing | in the filing |
| KAT Construction Services | KATX, NYSE American | $5 to $7 range, 29 Oct | $12.6M | loss of $0.8M | $0.57M |
| NuvOx Therapeutics | NUOX, NYSE American | $6 to $8 range, 29 Oct | $1.0M | loss of $10.0M | $0.43M |
| Starton Holdings | STA, Nasdaq | $5 to $7 range, 28 Oct | none yet | loss of $15.2M | $1.4M |
| Syntiant | none yet | Amended filing, July | in the filing | in the filing | in the filing |
Each filing in the response links to the SEC’s copy, so you can check any number. Your agent screens, you decide.
Screen the ten newest IPO filings from Financial Datasets through TaskFuel. Which ones have revenue, a profit, and at least a year of cash at their current pace? Show your reasoning, link each filing, and tell me what the call cost.
What else your agent can read now
All 36 Financial Datasets endpoints joined the TaskFuel catalog this week. IPO filings are one of them. The rest, priced from free quotes:
- Financial statements for listed companies, including revenue by segment: $0.02 a call
- Forward guidance and operating KPIs like airline load factors or same-store sales, pulled from earnings releases: $0.16
- Insider trades and 13F institutional holdings: $0.02
- Activist stakes and ETF holdings, in both directions: who holds this stock, and what this fund holds: $0.02
- SEC filings, earnings and company news: $0.02
- Macro data: interest rates, the yield curve, inflation, the labour market, and a daily rental-price index for H100 and newer GPUs: $0.02
Elsewhere in the catalog, your agent can also reach SEC full-text search, on-chain market data from Glassnode, crypto prices and Polymarket odds, all from the same balance.
Good to know
Through TaskFuel, history covers the last 365 days. Each page of results is its own call: ten IPO filings are one page, so twenty would be two. In this call, six of the ten filings came with their numbers extracted. For the other four, the link to the filing is there.
Your agent analyzes the data
With TaskFuel, your agent finds the data it needs, pulls it in, and does the analysis in the same conversation. It can go from IPO filings to insider trades to the yield curve as your questions change, with one TaskFuel account behind all of it.
Connect your agent and the first $1 is on us.
Find every company that filed to go public last month and made a profit over the last twelve months. Link each filing.
